Cargando…
(131)I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry
In 40–50% of colorectal cancer (CRC) cases, K-Ras gene mutations occur, which induce the expression of the K-Ras4B oncogenic isoform. K-Ras4B is transported by phosphodiesterase-6δ (PDE6δ) to the plasma membrane, where the K-Ras4B–PDE6δ complex dissociates and K-Ras4B, coupled to the plasma membrane...
Autores principales: | Cruz-Nova, Pedro, Ocampo-García, Blanca, Carrión-Estrada, Dayan Andrea, Briseño-Diaz, Paola, Ferro-Flores, Guillermina, Jiménez-Mancilla, Nallely, Correa-Basurto, José, Bello, Martiniano, Vega-Loyo, Libia, Thompson-Bonilla, María del Rocío, Hernández-Rivas, Rosaura, Vargas, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458062/ https://www.ncbi.nlm.nih.gov/pubmed/36080216 http://dx.doi.org/10.3390/molecules27175446 |
Ejemplares similares
-
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of (131)I during radioiodine therapy of Graves’ disease
por: Happel, C., et al.
Publicado: (2021) -
Implementation of iodine biokinetic model for interpreting I-131 contamination in breast milk after the Fukushima nuclear disaster
por: Tani, Kotaro, et al.
Publicado: (2015) -
Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer
por: Tian, Longlong, et al.
Publicado: (2017) -
The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo
por: Cruz-Nova, Pedro, et al.
Publicado: (2018) -
Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer
por: Briseño-Díaz, Paola, et al.
Publicado: (2023)